Trials / Completed
CompletedNCT05565339
PMEI Post-Market Clinical Follow-Up
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 497 (actual)
- Sponsor
- MED-EL Elektromedizinische Geräte GesmbH · Industry
- Sex
- All
- Age
- 0 Years – 99 Years
- Healthy volunteers
- —
Summary
Confirm safety and performance of passive middle ear implants (PMEIs) in subjects with pre-existing condition which made the implantation of a MED-EL PMEI necessary
Detailed description
Collect retrospective audiological and safety results of PMEI implanted subjects. A post-operative minimum and maximum follow-up period was not defined. The mean of the post-operative follow-up period of all patients was calculated.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | PMEIs | To evaluate audiological outcomes post-operatively, the air-bone gap (ABG) was assessed. To evaluate safety of the devices, adverse events were collected.A post-operative minimum and maximum follow-up period was not defined. The mean of the post-operative follow-up period of all patients was calculated. To assess whether implantation of PMEI affected residual hearing pre- and post-operative bone conduction thresholds were evaluated. |
Timeline
- Start date
- 2020-09-29
- Primary completion
- 2023-11-02
- Completion
- 2023-11-02
- First posted
- 2022-10-04
- Last updated
- 2023-12-15
Locations
11 sites across 3 countries: Austria, Germany, Poland
Source: ClinicalTrials.gov record NCT05565339. Inclusion in this directory is not an endorsement.